A 96-year-old woman with inherited type 2A von Willebrand disease and previously mild symptoms experienced a sudden worsening of bleeding after developing acquired von…
Treatment with all-trans retinoic acid (ATRA), a compound derived from vitamin A, may help restore production of clot-promoting platelets in people with immune thrombocytopenia (ITP), according to a study. Researchers found that the compound improved the ability of megakaryocytes — the large cells in the bone marrow responsible for…
Latest news & perspectives
Adding Cablivi (caplacizumab-yhdp) to standard treatment for immune-mediated thrombotic thrombocytopenic purpura (iTTP) may help protect the brain by repairing damage to the blood-brain barrier,…
Blocking the activity of an enzyme known as MELK may help boost the production of platelets — tiny cell fragments that improve blood clotting and…
